Millions more people will die annually from antibiotic-resistant infections over the next 25 years unless steps are taken to counter this growing health threat, a new study warns.. The number of ...

"Could move into the plains across states." Scientists sound alarm over growing threat of drug-resistant respiratory ...

“Antibiotic resistance is worse than we previously thought,” one expert says. A new report from the CDC says the U.S. sees 2.8 million antibiotic-resistant infections and over 35,000 resulting ...

Antibiotic resistance is a growing problem “Antibiotic-resistant UTIs are the canary in the coal mine for broader antibiotic resistance,” Dr. Robert Bonomo, antibiotic resistance researcher ...

Antibiotic-resistant Acinetobacter baumannii infections, one of the most common hospital-acquired infections in children across the United States, are on the rise.

The biggest driver of drug-resistant infections is the overuse, ... it was a challenging experience that made me much more aware of the growing issue of antibiotic resistance," he said.

Although nearly 50,000 Americans — and about 1.3 million people worldwide — die of resistant bacterial infections each year, the FDA has not approved a new antibiotic since 2019.

Antibiotic resistance’s growing toll: 12 numbers More than 39 million people are projected to die of antibiotic-resistant infections between 2025 and 2050, a first-of-its-kind study found.

According to a CDC report in 2019, nearly 3 million antibiotic-resistant infections occurred in people and more than 35,000 were killed from them.

A growing number of Americans are building immunity to antibiotics, which can make them more vulnerable to illnesses and infections. There are about 2.8 million antibiotic-resistant infections per ...

The presence of drug-resistant bacteria leads to infections that require new, more costly, and potentially toxic treatments. Antibiotic resistance is a major issue in agricultural applications.

However, these antibiotics are considered a "last-resort" treatment for many drug-resistant infections, because they target an extremely wide variety of bacteria.